Skip to content

Brain & Nervous System Health Center

FDA OKs Generic Requip

Approval Announced for Generic Versions of Requip Made by 4 Different Companies
Font Size
A
A
A
By
WebMD Health News
Reviewed by Louise Chang, MD

May 14, 2008 -- The FDA has approved generic versions of the drug Requip made by four companies.

Generic ropinirole hydrochloride will be made by Teva Pharmaceuticals USA, Roxane Laboratories, Mylan Pharmaceuticals, and Par Pharmaceutical.

Requip, made by GlaxoSmithKline, is used to treat restless legs syndrome and Parkinson's disease. Requip's patent expires on May 19, according to the FDA.

Restless legs syndrome (RLS) is a disorder in which people have an unpleasant feeling in their legs when lying down to sleep; they often have a strong urge to move their legs, making it difficult to sleep.

Parkinson's is a progressive disease in which there is a breakdown in the nerve cells in the brain that make dopamine. Symptoms include tremors, stiff muscles, slow movement, and problems with balance or walking.

Today on WebMD

nerve damage
Learn how this disease affects the nervous system.
senior woman with lost expression
Know the early warning signs.
 
woman in art gallery
Tips to stay smart, sharp, and focused.
medical marijuana plant
What is it used for?
 
senior man
Article
boy hits soccer ball with head
Slideshow
 
Graphic of active brain
Article
Vaccine and needle
VIDEO
 
brain illustration stroke
Slideshow
human brain
Article
 
most common stroke symptoms
Article
Graphic of number filled head and dna double helix
Quiz